Page 3 - ப்ரொஃபெஸர் ஆஃப் மருந்து இல் ஸ்டான்போர்ட் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரொஃபெஸர் ஆஃப் மருந்து இல் ஸ்டான்போர்ட் பல்கலைக்கழகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரொஃபெஸர் ஆஃப் மருந்து இல் ஸ்டான்போர்ட் பல்கலைக்கழகம் Today - Breaking & Trending Today

Prometheus Biosciences Announces Appointments of Judith L. Swain, MD and Helen C. Adams, CPA to its Board of Directors


Share this article
Share this article
SAN DIEGO, Feb. 16, 2021 /PRNewswire/ Prometheus Biosciences, Inc. ( Prometheus ), a biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease (IBD), today announced the appointments of Judith L. Swain, MD and Helen C. Adams to its board of directors.  Ms. Adams will assume the position of Chair of the Audit Committee.
We re thrilled to have Judith and Helen join our Board of Directors, who bring significant clinical medicine and financial expertise that will be important as we advance our pipeline to people living with IBD, said Mark McKenna, President and CEO of Prometheus.  Judith is a distinguished physician scientist and veteran scientific advisory board member with an international perspective on drug development.  Helen is an outstanding financial profession ....

Stanford University , United States , San Diego , San Marcos , National University Of Singapore , Singapore General , Tachi Yamada , Dermotp Mcgovern , Stephan Targan , Helenc Adams , Mark Mckenna , William Sandborn , Los Angeles , Judithl Swain , Agency For Science , University Of California , Technologies Ltd , Compensation Committee , Technology Group , Lexicon Pharmaceuticals Inc , Audit Committee , Audit Committee Chair , Singapore Institute For Clinical Sciences , Physiowave Inc , California State University At San Marcos Foundation , Prometheus Biosciences Inc ,

Visby Medical's COVID-19 PCR Point of Care Test Authorized for Use in CLIA Waived Settings


Share this article
Share this article
SAN JOSE, Calif., Feb. 10, 2021 /PRNewswire/ Visby Medical™ announced today the US Food and Drug Administration (FDA) authorized Visby s rapid PCR COVID-19 test for use at the point of care (POC). Building on the FDA s emergency use authorization granted earlier this year, Visby Medical s rapid PCR COVID-19 test may now be used by any organization with a Clinical Laboratory Improvement Amendments (CLIA) certificate of waiver.
Visby Medical Test - Now Authorized for CLIA-Waived Settings
It is imperative that the best tools are available to fight infection, protect the most vulnerable and maintain essential operations. PCR testing has been acknowledged as the gold standard for its high level of accuracy, but has drawbacks including the reliance on centralized labs and long wait times for results. ....

Gary Schoolnik , Professor Of Medicine At Stanford University , Visby Medical , Chief Medical Officer , Stanford University , Chief Executive Officer , Stefanie Tuck , ப்ரொஃபெஸர் ஆஃப் மருந்து இல் ஸ்டான்போர்ட் பல்கலைக்கழகம் , தலைமை மருத்துவ அதிகாரி , ஸ்டான்போர்ட் பல்கலைக்கழகம் , தலைமை நிர்வாகி அதிகாரி , ஸ்தேபனிே டக் ,